Coulter & Justus Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Coulter & Justus Financial Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,055	Closed	-$359K	–	50
2022 Q3	$359K	Hold	5,055	–	–	0.28%	31
2022 Q2	$389K	Buy	+5,055	New	+$385K	0.31%	30
2022 Q1	–	Sell	-30,435	Closed	-$1.9M	–	19
2021 Q4	$1.9M	Buy	+30,435	New	+$1.79M	1.49%	19

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Coulter & Justus Financial Services's BMY Position: Q4 2022 in Review

Coulter & Justus Financial Services sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 5,055 shares — an estimated $359K sold.

Coulter & Justus Financial Services first reported a position in BMY in Q4 2021 and held it in 3 quarters. The position peaked at $1.9M in Q4 2021. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Coulter & Justus Financial Services reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
Coulter & Justus Financial Services sold 5,055 Bristol-Myers Squibb shares in Q4 2022, an estimated $359K.
Coulter & Justus Financial Services first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 3 quarters.
Coulter & Justus Financial Services's Bristol-Myers Squibb position peaked at $1.9M in Q4 2021.
2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Coulter & Justus Financial Services's 13F filing for Q4 2022, filed 10 Feb 2023.